Beijing, Beijing, China The fund was located in Europe if to be more exact in France. The main department of described VC is located in the Paris.
The common things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 38 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Cathay Capital performs on 13 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The average startup value when the investment from Cathay Capital is 500 millions - 1 billion dollars. The important activity for fund was in 2018.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Cathay Capital, startups are often financed by Shunwei Capital, Morningside Venture Capital, ZhenFund. The meaningful sponsors for the fund in investment in the same round are Shunwei Capital, Yunmu Capital, Tencent Holdings. In the next rounds fund is usually obtained by Gaorong Capital, Yunmu Capital, Tencent Holdings.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Chemical, Electronics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the various public portfolio startups of the fund, we may underline Pinduoduo, Origene Technologies, Tongshifu The fund has exact preference in a number of founders of portfolio startups.
Besides them, we counted 7 critical employees of this fund in our database.
| Fund Name | Location |
| Accelerate Ventures | Springville, United States, Utah |
| Allegis Capital | California, San Francisco, United States |
| BAT Capital | Beijing, Beijing, China |
| Chiesi Pharmaceuticals | Emilia-Romagna, Italy, Parma |
| Florida Growth Fund | Florida, Fort Lauderdale, United States |
| G2H2 Capital | New York, New York, United States |
| Hack Secure | Boston, Massachusetts, United States |
| Haier Open Partnership Ecosystem (HOPE) | China, Japan, Kagoshima Prefecture |
| Jianxin Capital | China, Shanghai |
| Monogram Capital Partners | Beverly Hills, California, United States |
| Norvestor Equity | Norway, Oslo |
| OostNL | Apeldoorn, Gelderland, The Netherlands |
| Properties | Chicago, Illinois, United States |
| SIP Joinne MingYuan Venture Capital | China, Jiangsu, Suzhou |
| Stahl Invest | - |
| Stonewood Capital Management | Pennsylvania, Pittsburgh, United States |
| Sustainable Income Capital Management | - |
| Wildcat Capital Management | Fort Worth, Texas, United States |
| Winfield Capital Corp | New York, United States, White Plains |
| Yuku Guoji | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
USHOPAL | $30M | 24 Sep 2018 | Shanghai | ||
USHOPAL | 01 May 2018 | Shanghai, China | |||
| $463K | 01 Mar 2015 | China, Beijing |
– Kojin Therapeutics Inc. launched with a $60m Series A led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital, with participation from Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, the Dana-Farber Cancer Institute’s Binney Street Capital, and several family offices.
– The company plans to use the proceeds of the Series A to accelerate its drug discovery platform based on its groundbreaking approach to cell state and ferroptosis biology and advance a robust pipeline of therapeutics, with an initial focus on oncology.
– Momenta, a Chinese autonomous driving startup, raised $500m funding.
– The round was led by SAIC Motor, Toyota and Bosch.
– Other participants included Mercedes-Benz AG, Xiaomi founder Lei Jun’s Shunwei Capital, Tencent, Cathay Capital and a few undisclosed institutions.
– It’s rare to see Tencent and Alibaba (or their affiliates) co-invest.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
USHOPAL | $30M | 24 Sep 2018 | Shanghai | ||
USHOPAL | 01 May 2018 | Shanghai, China | |||
| $463K | 01 Mar 2015 | China, Beijing |
